Stay Updated
Press Releases
WASHINGTON, D.C. — Patients For Affordable Drugs released an extensive fact check today that takes on Big Pharma’s lies in recent ads, which total more than $18 million this year, attacking drug pricing reforms that include allowing Medicare to negotiate lower drug prices. The fact check breaks down six false claims in pharma-funded ads, including misleading […]
Reports
Press Releases
WASHINGTON, D.C. — The following statement was issued by David Mitchell, a cancer patient and founder of Patients For Affordable Drugs, in response to the Food and Drug Administration’s approval of Mylan’s Semglee as an interchangeable biosimilar to Sanofi’s long-acting Lantus (glargine) insulin: “The FDA’s approval of Semglee as an interchangeable biosimilar to Lantus is an […]
Press Releases
NEW ANALYSIS: Drug Companies Continue To Hike Prices At Will; Congress Must Act
WASHINGTON, D.C. — As the drug industry continues to hike drug prices at will, a new analysis from Patients For Affordable Drugs gives evidence of the urgent need for Congress to lower drug prices by allowing Medicare to negotiate directly with drug companies. The analysis explores more than 1,000 price hikes since the beginning of 2021 […]
Press Releases
WASHINGTON, D.C.— Patients For Affordable Drugs founder David Mitchell will testify before the Senate Judiciary Subcommittee on Competition Policy, Antitrust, and Consumer Rights today at a hearing titled A Prescription for Change: Cracking Down on Anticompetitive Conduct in Prescription Drug Markets. Mitchell, who depends on innovation and new drugs to stay alive in the face […]